Selected research
Market Structure
Global Amantadine Hydrochloride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Amantadine Hydrochloride market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Amantadine Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Amantadine Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Amantadine Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Amantadine Hydrochloride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Amantadine Hydrochloride include Actavis, Cipla, Hi-Tech Pharma, Pai Pharma, Protec, NE Pharma, Hengshan Pharma, Wantong Pharma and Pengyao Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Amantadine Hydrochloride market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Amantadine Hydrochloride and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Amantadine Hydrochloride sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amantadine Hydrochloride market size, projected growth trends, production technologies, key applications, and end-use industries.
Amantadine Hydrochloride Segment by Company
Actavis
Cipla
Hi-Tech Pharma
Pai Pharma
Protec
NE Pharma
Hengshan Pharma
Wantong Pharma
Pengyao Pharma
Purina Biotechnology
SANDOZ
Taiyi Phrama
Sine Phrama
Amantadine Hydrochloride Segment by Type
Tablets
Oral Solution
Amantadine Hydrochloride Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Amantadine Hydrochloride Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amantadine Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amantadine Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amantadine Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Amantadine Hydrochloride market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amantadine Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Amantadine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Amantadine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Oral Solution
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Companies covered
- Actavis
- Cipla
- Hi-Tech Pharma
- Pai Pharma
- Protec
- NE Pharma
- Hengshan Pharma
- Wantong Pharma
- Pengyao Pharma
- Purina Biotechnology
- SANDOZ
- Taiyi Phrama
- Sine Phrama
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Amantadine Hydrochloride Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Amantadine Hydrochloride Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Amantadine Hydrochloride Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Amantadine Hydrochloride Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Amantadine Hydrochloride Market Dynamics
- 2.1 Amantadine Hydrochloride Industry Trends
- 2.2 Amantadine Hydrochloride Industry Drivers
- 2.3 Amantadine Hydrochloride Industry Opportunities and Challenges
- 2.4 Amantadine Hydrochloride Industry Restraints
3 Amantadine Hydrochloride Market by Manufacturers
- 3.1 Global Amantadine Hydrochloride Revenue by Manufacturers (2021-2026)
- 3.2 Global Amantadine Hydrochloride Sales by Manufacturers (2021-2026)
- 3.3 Global Amantadine Hydrochloride Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Amantadine Hydrochloride Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Amantadine Hydrochloride Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Amantadine Hydrochloride Manufacturers, Product Type & Application
- 3.7 Global Amantadine Hydrochloride Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Amantadine Hydrochloride Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Amantadine Hydrochloride Players Market Share by Revenue in 2025
- 3.8.3 2025 Amantadine Hydrochloride Tier 1, Tier 2, and Tier 3
4 Amantadine Hydrochloride Market by Type
- 4.1 Amantadine Hydrochloride Type Introduction
- 4.1.1 Tablets
- 4.1.2 Oral Solution
- 4.2 Global Amantadine Hydrochloride Sales by Type
- 4.2.1 Global Amantadine Hydrochloride Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Amantadine Hydrochloride Sales by Type (2021-2032)
- 4.2.3 Global Amantadine Hydrochloride Sales Market Share by Type (2021-2032)
- 4.3 Global Amantadine Hydrochloride Revenue by Type
- 4.3.1 Global Amantadine Hydrochloride Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Amantadine Hydrochloride Revenue by Type (2021-2032)
- 4.3.3 Global Amantadine Hydrochloride Revenue Market Share by Type (2021-2032)
5 Amantadine Hydrochloride Market by Application
- 5.1 Amantadine Hydrochloride Application Introduction
- 5.1.1 Retail Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Hospital Pharmacies
- 5.2 Global Amantadine Hydrochloride Sales by Application
- 5.2.1 Global Amantadine Hydrochloride Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Amantadine Hydrochloride Sales by Application (2021-2032)
- 5.2.3 Global Amantadine Hydrochloride Sales Market Share by Application (2021-2032)
- 5.3 Global Amantadine Hydrochloride Revenue by Application
- 5.3.1 Global Amantadine Hydrochloride Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Amantadine Hydrochloride Revenue by Application (2021-2032)
- 5.3.3 Global Amantadine Hydrochloride Revenue Market Share by Application (2021-2032)
6 Global Amantadine Hydrochloride Sales by Region
- 6.1 Global Amantadine Hydrochloride Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Amantadine Hydrochloride Sales by Region (2021-2032)
- 6.2.1 Global Amantadine Hydrochloride Sales by Region (2021-2026)
- 6.2.2 Global Amantadine Hydrochloride Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Amantadine Hydrochloride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Amantadine Hydrochloride Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Amantadine Hydrochloride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Amantadine Hydrochloride Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Amantadine Hydrochloride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Amantadine Hydrochloride Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Amantadine Hydrochloride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Amantadine Hydrochloride Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Amantadine Hydrochloride Revenue by Region
- 7.1 Global Amantadine Hydrochloride Revenue by Region
- 7.1.1 Global Amantadine Hydrochloride Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Amantadine Hydrochloride Revenue by Region (2021-2026)
- 7.1.3 Global Amantadine Hydrochloride Revenue by Region (2027-2032)
- 7.1.4 Global Amantadine Hydrochloride Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Amantadine Hydrochloride Revenue (2021-2032)
- 7.2.2 North America Amantadine Hydrochloride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Amantadine Hydrochloride Revenue (2021-2032)
- 7.3.2 Europe Amantadine Hydrochloride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Amantadine Hydrochloride Revenue (2021-2032)
- 7.4.2 Asia-Pacific Amantadine Hydrochloride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Amantadine Hydrochloride Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Amantadine Hydrochloride Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Actavis
- 8.1.1 Actavis Company Information
- 8.1.2 Actavis Business Overview
- 8.1.3 Actavis Amantadine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Actavis Amantadine Hydrochloride Product Portfolio
- 8.1.5 Actavis Recent Developments
- 8.2 Cipla
- 8.2.1 Cipla Company Information
- 8.2.2 Cipla Business Overview
- 8.2.3 Cipla Amantadine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Cipla Amantadine Hydrochloride Product Portfolio
- 8.2.5 Cipla Recent Developments
- 8.3 Hi-Tech Pharma
- 8.3.1 Hi-Tech Pharma Company Information
- 8.3.2 Hi-Tech Pharma Business Overview
- 8.3.3 Hi-Tech Pharma Amantadine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Hi-Tech Pharma Amantadine Hydrochloride Product Portfolio
- 8.3.5 Hi-Tech Pharma Recent Developments
- 8.4 Pai Pharma
- 8.4.1 Pai Pharma Company Information
- 8.4.2 Pai Pharma Business Overview
- 8.4.3 Pai Pharma Amantadine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Pai Pharma Amantadine Hydrochloride Product Portfolio
- 8.4.5 Pai Pharma Recent Developments
- 8.5 Protec
- 8.5.1 Protec Company Information
- 8.5.2 Protec Business Overview
- 8.5.3 Protec Amantadine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Protec Amantadine Hydrochloride Product Portfolio
- 8.5.5 Protec Recent Developments
- 8.6 NE Pharma
- 8.6.1 NE Pharma Company Information
- 8.6.2 NE Pharma Business Overview
- 8.6.3 NE Pharma Amantadine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 NE Pharma Amantadine Hydrochloride Product Portfolio
- 8.6.5 NE Pharma Recent Developments
- 8.7 Hengshan Pharma
- 8.7.1 Hengshan Pharma Company Information
- 8.7.2 Hengshan Pharma Business Overview
- 8.7.3 Hengshan Pharma Amantadine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Hengshan Pharma Amantadine Hydrochloride Product Portfolio
- 8.7.5 Hengshan Pharma Recent Developments
- 8.8 Wantong Pharma
- 8.8.1 Wantong Pharma Company Information
- 8.8.2 Wantong Pharma Business Overview
- 8.8.3 Wantong Pharma Amantadine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Wantong Pharma Amantadine Hydrochloride Product Portfolio
- 8.8.5 Wantong Pharma Recent Developments
- 8.9 Pengyao Pharma
- 8.9.1 Pengyao Pharma Company Information
- 8.9.2 Pengyao Pharma Business Overview
- 8.9.3 Pengyao Pharma Amantadine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Pengyao Pharma Amantadine Hydrochloride Product Portfolio
- 8.9.5 Pengyao Pharma Recent Developments
- 8.10 Purina Biotechnology
- 8.10.1 Purina Biotechnology Company Information
- 8.10.2 Purina Biotechnology Business Overview
- 8.10.3 Purina Biotechnology Amantadine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Purina Biotechnology Amantadine Hydrochloride Product Portfolio
- 8.10.5 Purina Biotechnology Recent Developments
- 8.11 SANDOZ
- 8.11.1 SANDOZ Company Information
- 8.11.2 SANDOZ Business Overview
- 8.11.3 SANDOZ Amantadine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 SANDOZ Amantadine Hydrochloride Product Portfolio
- 8.11.5 SANDOZ Recent Developments
- 8.12 Taiyi Phrama
- 8.12.1 Taiyi Phrama Company Information
- 8.12.2 Taiyi Phrama Business Overview
- 8.12.3 Taiyi Phrama Amantadine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Taiyi Phrama Amantadine Hydrochloride Product Portfolio
- 8.12.5 Taiyi Phrama Recent Developments
- 8.13 Sine Phrama
- 8.13.1 Sine Phrama Company Information
- 8.13.2 Sine Phrama Business Overview
- 8.13.3 Sine Phrama Amantadine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Sine Phrama Amantadine Hydrochloride Product Portfolio
- 8.13.5 Sine Phrama Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Amantadine Hydrochloride Value Chain Analysis
- 9.1.1 Amantadine Hydrochloride Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Amantadine Hydrochloride Production Mode & Process
- 9.2 Amantadine Hydrochloride Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Amantadine Hydrochloride Distributors
- 9.2.3 Amantadine Hydrochloride Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst